Related Experiment Videos
Small, blue collar work site hypertension screening: a cost-effectiveness study
E Ellis1, W Koblin, M J Irvine
1Ottawa-Carleton Health Department, Ontario, Canada.
Summary
One-stage hypertension screening is as effective and cost-effective as two-stage screening in blue-collar workplaces. This simpler approach is recommended for easier implementation and similar health outcomes in occupational health settings.
Area of Science:
- Occupational Health
- Public Health
- Cardiovascular Disease Prevention
Background:
- Hypertension screening in workplace settings is crucial for early detection and management.
- Assessing the cost-effectiveness of different screening strategies is essential for resource allocation.
- Multicultural, blue-collar work sites present unique challenges for health interventions.
Purpose of the Study:
- To compare the cost-effectiveness of one-stage versus two-stage hypertension screening.
- To evaluate the impact of different screening protocols on hypertension control in workers.
- To determine the preferred screening strategy for small to medium-sized blue-collar workplaces.
Main Methods:
- Randomized allocation of workers with elevated diastolic blood pressure (DBP) to one- or two-stage screening.
- Implementation of differing physician referral protocols based on DBP and treatment status.
- Assessment of outcomes including DBP decrease, physician visits, and medication control at one year.
Main Results:
- No significant differences in effects or cost-effectiveness between one-stage and two-stage screening after one year.
- Both groups achieved a significant decrease in DBP (8.5 mm Hg).
- 54% of participants saw a physician within the recommended timeframe, and 50% achieved controlled blood pressure.
Conclusions:
- One-stage hypertension screening is a viable and preferred option due to its ease of implementation.
- Both screening methods yielded comparable health outcomes and cost-effectiveness.
- Worksite hypertension screening programs can effectively improve cardiovascular health in blue-collar populations.